
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+12
Innovative medicine for everyone, everywhere Listed on the Euronext stock market, Adocia is a clinical-stage biotech company specialized in the development of best-in-class medicine relying on innovative formulations of already-approved therapeutic proteins. Adocia is specialized in diabetes and obesity. The proprietary BioChaperone technological platform is designed to enhance the effectiveness and safety of therapeutic proteins and their ease of use for patients. For more information, visit our website: www.adocia.com For careers offers, please click to the following link : https://www.adocia.com/careers/adocia-careers
Therapeutic proteins,biochaperone®, next-generation injectables for diabetes treatment, ultra-rapid insulin,multi-agents injectable combination,diabetes,metabolic diseases,amylin,innovative protein formulations,glucagon,insulin,glp-1,obesity,cell therapy,transplantation of islets of langherans,long acting injectables,and oral formulation of peptides
Adocia operates in the Biotechnology research industry.
Adocia's revenue is 1m - 10m
Adocia has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.